Publikationen

Olafsdottir, T. A.; Lindqvist, M.; Nookaew, I.; Andersen, P.; Maertzdorf, J.; Persson, J.; Christensen, D.; Zhang, Y.; Anderson, J.; Khoomrung, S. et al.; Sen, P.; Agger, E. M.; Coler, R.; Carter, D.; Meinke, A.; Rappuoli, R.; Kaufmann, S. H. E.; Reed, S. G.; Harandi, A. M.: Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants. Scientific Reports 6, 39097 (2016)

Zimmermann, N.; Saiga, H.; Houthuys, E.; Moura-Alves, P.; Koehler, A.; Bandermann, S.; Dorhoi, A.; Kaufmann, S. H. E.: Syndecans promote mycobacterial internalization by lung epithelial cells. Cellular Microbiology 18 (12), S. 1846 - 1856 (2016)

Perdomo, C.; Zedler, U.; Kühl, A. A.; Lozza, L.; Saikali, P.; Sander, L. E.; Vogelzang, A.; Kaufmann, S. H. E.; Kupz, A.: Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis. mBio 7 (6), e01686-16 (2016)

Bayer-Santos, E.; Durkin, C. H.; Rigano, L. A.; Kupz, A.; Alix, E.; Cerny, O.; Jennings, E.; Liu, M.; Ryan, A. S.; Lapaque, N. et al.; Kaufmann, S. H. E.; Holden, D. W.: The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation. Cell Host & Microbe 20 (5), S. 584 - 595 (2016)

Lachmandas, E.; Beigier-Bompadre, M.; Cheng, S.-C.; Kumar, V.; van Laarhoven, A.; Wang, X.; Ammerdorffer, A.; Boutens, L.; de Jong, D.; Kanneganti, T.-D. et al.; Gresnigt, M. S.; Ottenhoff, T. H.M.; Joosten, L. A.B.; Stienstra, R.; Wijmenga, C.; Kaufmann, S. H. E.; van Crevel, R.; Netea, M. G.: Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. European Journal of Immunology 46 (11), S. 2574 - 2586 (2016)

Zimmermann, N.; Thormann, V.; Hu, B.; Köhler, A.-B.; Imai-Matsushima, A.; Locht, C.; Arnett, E.; Schlesinger, L. S.; Zoller, T.; Schürmann, M. et al.; Kaufmann, S. H. E.; Wardemann, H.: Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis. EMBO Molecular medicine 8 (11), S. 1325 - 1339 (2016)

Streata, I.; Weiner, J. 3.; Iannaccone, M.; McEwen, G.; Ciontea, M. S.; Olaru, M.; Capparelli, R.; Ioana, M.; Kaufmann, S. H. E.; Dorhoi, A.: Correction: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis. PLoS One 11 (10), e0165853 (2016)

Wu, M.-L.; Gengenbacher, M.; Chung, J. C. S.; Chen, S. L.; Mollenkopf, H.-J.; Kaufmann, S. H. E.; Dick, T.: Developmental transcriptome of resting cell formation in Mycobacterium smegmatis. BMC Genomics 17 (1), 837 (2016)

Vogelzang, A.; Lozza, L.; Reece, S. T.; Perdomo, C.; Zedler, U.; Hahnke, K.; Oberbeck-Mueller, D.; Dorhoi, A.; Kaufmann, S. H. E.: Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis. Infection and Immunity 84 (10), S. 2914 - 2921 (2016)

Streata, I.; Weiner, J. 3.; Iannaconne, M.; McEwen, G.; Ciontea, M. S.; Olaru, M.; Capparelli, R.; Ioana, M.; Kaufmann, S. H. E.; Dorhoi, A.: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis. PLoS One 11 (9), e0163662 (2016)

Awoniyi, D. O.; Teuchert, A.; Sutherland, J. S.; Mayanja-Kizza, H.; Howe, R.; Mihret, A.; Loxton, A. G.; Sheehama, J.; Kassa, D.; Crampin, A. C. et al.; Dockrell, H. M.; Kidd, M.; Rosenkrands, I.; Geluk, A.; Ottenhoffk, T. H.M.; Corstjens, P.L.A.M.; Chegou, N. N.; Walzl, G.; AE-TBC Consortium; Kaufmann, S. H. E.; Esterhuyse, M. M.: Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease. Journal of infection 73 (3), S. 219 - 230 (2016)

Chegou, N. N.; Sutherland, J. S.; Malherbe, S.; Crampin, A. C.; Corstjens, P. L. A. M.; Geluk, A.; Mayanja-Kizza, H.; Loxton, A. G.; van der Spuy, G.; Stanley, K. et al.; Kotzé, L. A.; van der Vyver, M.; Rosenkrands, I.; Kidd, M.; van Helden, P. D.; Dockrell, H. M.; Ottenhoff, T. H. M.; Kaufmann, S. H. E.; Walzl, G.: Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. Thorax 71 (9), S. 785 - 794 (2016)

Scriba, T. J.; Kaufmann, S. H. E.; Lambert, P. H.; Sanicas, M.; Martin, C.; Neyrolles, O.: Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines. The Journal of Infectious Diseases 214 (5), S. 659 - 664 (2016)

Ahsan, F.; Moura-Alves, P.; Guhlich-Bornhof, U.; Klemm, M.; Kaufmann, S. H. E.; Maertzdorf, J.: Role of Interleukin 36γ in Host Defense Against Tuberculosis. The Journal of Infectious Diseases 214 (3), S. 464 - 474 (2016)

Kaufmann, S. H. E.; Fortune, S.; Pepponi, I.; Ruhwald, M.; Schrager, L. K.; Ottenhoff, T. H.M.: TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines. Tuberculosis 99 (Suppl. 1), S. S8 - S11 (2016)

Kupz, A.; Zedler, U.; Stäber, M.; Kaufmann, S. H. E.: A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation. PLoS One 11 (7), e0158849 (2016)

Kaufmann, S. H. E.: EFIS lecture. Immune response to tuberculosis: How to control the most successful pathogen on earth. Immunology Letters 175, S. 50 - 57 (2016)

Zak, D. E.; Penn-Nicholson, A.; Scriba, T. J.; Thompson, E.; Suliman, S.; Amon, L. M.; Mahomed, H.; Erasmus, M.; Whatney, W.; Hussey, G. D. et al.; Abrahams, D.; Kafaar, F.; Hawkridge, T.; Verver, S.; Hughes, E. J.; Ota, M.; Sutherland, J.; Howe, R.; Dockrell, H. M.; Boom, W. H.; Thiel, B.; Ottenhoff, T. H. M.; Mayanja-Kizza, H.; Crampin, A. C.; Downing, K.; Hatherill, M.; Valvo, J.; Shankar, S.; Parida, S. K.; Kaufmann, S. H. E.; Walzl, G.; Aderem, A.; Hanekom, W. A.: A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387 (10035), S. 2312 - 2322 (2016)

Kupz, A.; Zedler, U.; Stäber, M.; Perdomo, C.; Dorhoi, A.; Brosch, R.; Kaufmann, S. H. E.: ESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo. The Journal of Clinical Investigation 126 (6), S. 2109 - 2122 (2016)

Gengenbacher, M.; Nieuwenhuizen, N.; Vogelzang, A.; Liu, H.; Kaiser, P.; Schuerer, S.; Lazar, D.; Wagner, I.; Mollenkopf, H.-J.; Kaufmann, S. H. E.: Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. mBio 7 (3), e00679-16 (2016)